DDL-218
DL-218 is an orally active SirT1 inhibitor. In models with neurons expressing ApoE4 and Alzheimer's disease (AD) mice, DL-218 enhances SirT1. It is applicable for research in Alzheimer's disease.
Product Specifications
CAS Number
2767324-34-3
Field of Research
Epigenetics & Chromatin, Molecular Biology, Stem Cell & Developmental Biology
Smiles
C (C (OC ([C@H] (C) N) =O) (C) C) C=1C=CN=CC1
Molecular Formula
C12H18N2O2
Molecular Weight
222.28
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1223554-01 0.02 mg (E-Coli)
Recombinant Rhizobium etli Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B
Sign In for Pricing
View Details MBS1223554-02 0.02 mg (Yeast)
Recombinant Rhizobium etli Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B
Sign In for Pricing
View Details MBS1223554-03 0.1 mg (E-Coli)
Recombinant Rhizobium etli Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B
Sign In for Pricing
View Details MBS1223554-04 0.1 mg (Yeast)
Recombinant Rhizobium etli Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B
Sign In for Pricing
View Details MBS1223554-05 0.02 mg (Baculovirus)
Recombinant Rhizobium etli Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B
Sign In for Pricing
View Details